Immunohistochemistry analysis revealed that IKE treatment resulted in significant reductions in SLC7A11 and Ki67 levels, as well as increases in 4-HNE levels in tumor tissues (Fig. 7I). This evidence concerns the gene MKI67 and neoplasm.